Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems
Platinum (Pt) drugs (e.g., oxaliplatin, cisplatin) are applied in the clinic worldwide for the treatment of various cancers. However, platinum-induced peripheral neuropathy (PIPN) caused by the accumulation of Pt in the peripheral nervous system limits the clinical application, whose prevention and...
Guardado en:
Autores principales: | Xi Hu, Zhijie Jiang, Longyu Teng, Hongyu Yang, Dongsheng Hong, Dongsheng Zheng, Qingwei Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3fc2826dd5a94c7f9e771266763cc593 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis
por: Yang F, et al.
Publicado: (2017) -
Multivalent nanosystems: targeting monocytes/macrophages
por: Poupot R, et al.
Publicado: (2018) -
Clinical and Genetic Features of Biallelic Mutations in SORD in a Series of Chinese Patients With Charcot-Marie-Tooth and Distal Hereditary Motor Neuropathy
por: Xiaoxuan Liu, et al.
Publicado: (2021) -
Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
por: Irfan MM, et al.
Publicado: (2021) -
A Combined Antitumor Strategy Mediated by a New Targeted Nanosystem to Hepatocellular Carcinoma
por: Farinha D, et al.
Publicado: (2021)